Breaking News

Purdue Pharma Canada Names Corporate Affairs VP

May 16, 2014

Perry responsible for patient access strategies

Grant Perry has been appointed vice president, Government and Corporate Affairs, Purdue Pharma Canada. Mr. Perry will also be responsible for the development and implementation of strategies providing patient access to Purdue's current and future marketed products. Mr. Perry reports to Dr. Craig Landau, president and chief executive officer, and will serve on the executive leadership team.
 
Mr. Perry joins the company from GlaxoSmithKline, where he spent the last 15 years, most recently as vice president, Public Affairs and Reimbursement. He previously held leadership roles within the primary care pharmaceutical and vaccine businesses. Mr. Perry also held roles with Industry Canada and the Pharmaceutical Manufacturers Association of Canada. 
 
Dr. Landau, said, "Grant's impressive work in policy, patient advocacy and market access at both the federal and provincial levels has earned him the reputation of being among the top in his field. His many years of experience and proven record of accomplishment will help Purdue pursue new growth opportunities, while solidifying its position as the leading innovative analgesic pharmaceutical company in Canada.”
 

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important